Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group (Q27011661)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group |
scientific article |
Statements
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group (English)
Patrick Kupelian
Steven Frank
Mark Scholz
Peter Grimm
Ignace Billiet
David Bostwick
Jos Immerzeel
Mira Keyes
Stefan Machtens
Jyoti Mayadev
Gregory Merrick
Richard Stock
Katsuto Shinohara
Ed Weber
Anthony Zietman
Jason Wong
Stacy Wentworth
Robyn Vera
Stephen Langley
W Robert Lee
Brian J Moran
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
2 references